Glaucoma is a complex disease that can result in progressive vision loss. It is the second leading cause of blindness, accounting for 23% of permanent blindness in Hong Kong. There are no treatments that restore vision lost to glaucoma. This study will examine the effect of transcranial direct current stimulation (NIBS) on improving quality of life, visual function and functional performance in patients with peripheral field loss due to glaucoma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Visual field test
Timeframe: Baseline (before the first intervention session), and immediately before and after each intervention block (5 session of intervention)
Electroencephalography (EEG)
Timeframe: Baseline (before the first intervention session), and immediately before and after each intervention block (5 session of intervention)
Optical Coherence Tomography (OCT)
Timeframe: Baseline (before the first intervention session), and immediately before and after each intervention block (5 session of intervention)
Optical Coherence Tomography Angiography (OCT-A)
Timeframe: Baseline (before the first intervention session), and immediately before and after each intervention block (5 session of intervention)